The global market for Cell STR Testing Service was valued at US$ 356 million in the year 2024 and is projected to reach a revised size of US$ 568 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Cell STR (Short Tandem Repeat) testing service is a molecular biology technology based on STR locus analysis, mainly used for cell line identification, cross contamination detection, and cell genetic stability analysis. STR testing achieves unique identification of cell lines by analyzing specific short repeat sequences in cell DNA, ensuring the reliability of cell line sources used in experiments and biopharmaceutical research, and preventing misuse or contamination.
North American market for Cell STR Testing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell STR Testing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell STR Testing Service in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell STR Testing Service include ATCC, Eurofins Genomics, Promega Corporation, Multiplexio, Shanghai Beyotime, Xiamen Immocell Biotechnology, Wuhan Boster Biological Technology, Beijing Microread Genetics, Beijing Abace Biology, Wuhan Pricella Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell STR Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell STR Testing Service.
The Cell STR Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell STR Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell STR Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
ATCC
Eurofins Genomics
Promega Corporation
Multiplexio
Shanghai Beyotime
Xiamen Immocell Biotechnology
Wuhan Boster Biological Technology
Beijing Microread Genetics
Beijing Abace Biology
Wuhan Pricella Biotechnology
Shanghai XP Biomed
Guangzhou IGE Biotechnology
Shanghai Zhong Qiao Xin Zhou Biotechnology
Shanghai Biowing Biotechnology Application
Tianjin KMD Bioscience
Wuhan Sunncell
Segment by Type
Human Cell STR Test
Mouse Cell STR Test
Others
Segment by Application
Pharmaceutical
Scientific Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell STR Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cell STR Testing Service 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Human Cell STR Test
1.2.3 Mouse Cell STR Test
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Cell STR Testing Service 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell STR Testing Service 麻豆原创 Perspective (2020-2031)
2.2 Global Cell STR Testing Service Growth Trends by Region
2.2.1 Global Cell STR Testing Service 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell STR Testing Service Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Cell STR Testing Service Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Cell STR Testing Service 麻豆原创 Dynamics
2.3.1 Cell STR Testing Service Industry Trends
2.3.2 Cell STR Testing Service 麻豆原创 Drivers
2.3.3 Cell STR Testing Service 麻豆原创 Challenges
2.3.4 Cell STR Testing Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell STR Testing Service Players by Revenue
3.1.1 Global Top Cell STR Testing Service Players by Revenue (2020-2025)
3.1.2 Global Cell STR Testing Service Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Top Cell STR Testing Service Players by Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell STR Testing Service Revenue
3.4 Global Cell STR Testing Service 麻豆原创 Concentration Ratio
3.4.1 Global Cell STR Testing Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell STR Testing Service Revenue in 2024
3.5 Global Key Players of Cell STR Testing Service Head office and Area Served
3.6 Global Key Players of Cell STR Testing Service, Product and Application
3.7 Global Key Players of Cell STR Testing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell STR Testing Service Breakdown Data by Type
4.1 Global Cell STR Testing Service Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Cell STR Testing Service Forecasted 麻豆原创 Size by Type (2026-2031)
5 Cell STR Testing Service Breakdown Data by Application
5.1 Global Cell STR Testing Service Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Cell STR Testing Service Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Cell STR Testing Service 麻豆原创 Size (2020-2031)
6.2 North America Cell STR Testing Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell STR Testing Service 麻豆原创 Size by Country (2020-2025)
6.4 North America Cell STR Testing Service 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell STR Testing Service 麻豆原创 Size (2020-2031)
7.2 Europe Cell STR Testing Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell STR Testing Service 麻豆原创 Size by Country (2020-2025)
7.4 Europe Cell STR Testing Service 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell STR Testing Service 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Cell STR Testing Service 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell STR Testing Service 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Cell STR Testing Service 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell STR Testing Service 麻豆原创 Size (2020-2031)
9.2 Latin America Cell STR Testing Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell STR Testing Service 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Cell STR Testing Service 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell STR Testing Service 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Cell STR Testing Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell STR Testing Service 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Cell STR Testing Service 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ATCC
11.1.1 ATCC Company Details
11.1.2 ATCC Business Overview
11.1.3 ATCC Cell STR Testing Service Introduction
11.1.4 ATCC Revenue in Cell STR Testing Service Business (2020-2025)
11.1.5 ATCC Recent Development
11.2 Eurofins Genomics
11.2.1 Eurofins Genomics Company Details
11.2.2 Eurofins Genomics Business Overview
11.2.3 Eurofins Genomics Cell STR Testing Service Introduction
11.2.4 Eurofins Genomics Revenue in Cell STR Testing Service Business (2020-2025)
11.2.5 Eurofins Genomics Recent Development
11.3 Promega Corporation
11.3.1 Promega Corporation Company Details
11.3.2 Promega Corporation Business Overview
11.3.3 Promega Corporation Cell STR Testing Service Introduction
11.3.4 Promega Corporation Revenue in Cell STR Testing Service Business (2020-2025)
11.3.5 Promega Corporation Recent Development
11.4 Multiplexio
11.4.1 Multiplexio Company Details
11.4.2 Multiplexio Business Overview
11.4.3 Multiplexio Cell STR Testing Service Introduction
11.4.4 Multiplexio Revenue in Cell STR Testing Service Business (2020-2025)
11.4.5 Multiplexio Recent Development
11.5 Shanghai Beyotime
11.5.1 Shanghai Beyotime Company Details
11.5.2 Shanghai Beyotime Business Overview
11.5.3 Shanghai Beyotime Cell STR Testing Service Introduction
11.5.4 Shanghai Beyotime Revenue in Cell STR Testing Service Business (2020-2025)
11.5.5 Shanghai Beyotime Recent Development
11.6 Xiamen Immocell Biotechnology
11.6.1 Xiamen Immocell Biotechnology Company Details
11.6.2 Xiamen Immocell Biotechnology Business Overview
11.6.3 Xiamen Immocell Biotechnology Cell STR Testing Service Introduction
11.6.4 Xiamen Immocell Biotechnology Revenue in Cell STR Testing Service Business (2020-2025)
11.6.5 Xiamen Immocell Biotechnology Recent Development
11.7 Wuhan Boster Biological Technology
11.7.1 Wuhan Boster Biological Technology Company Details
11.7.2 Wuhan Boster Biological Technology Business Overview
11.7.3 Wuhan Boster Biological Technology Cell STR Testing Service Introduction
11.7.4 Wuhan Boster Biological Technology Revenue in Cell STR Testing Service Business (2020-2025)
11.7.5 Wuhan Boster Biological Technology Recent Development
11.8 Beijing Microread Genetics
11.8.1 Beijing Microread Genetics Company Details
11.8.2 Beijing Microread Genetics Business Overview
11.8.3 Beijing Microread Genetics Cell STR Testing Service Introduction
11.8.4 Beijing Microread Genetics Revenue in Cell STR Testing Service Business (2020-2025)
11.8.5 Beijing Microread Genetics Recent Development
11.9 Beijing Abace Biology
11.9.1 Beijing Abace Biology Company Details
11.9.2 Beijing Abace Biology Business Overview
11.9.3 Beijing Abace Biology Cell STR Testing Service Introduction
11.9.4 Beijing Abace Biology Revenue in Cell STR Testing Service Business (2020-2025)
11.9.5 Beijing Abace Biology Recent Development
11.10 Wuhan Pricella Biotechnology
11.10.1 Wuhan Pricella Biotechnology Company Details
11.10.2 Wuhan Pricella Biotechnology Business Overview
11.10.3 Wuhan Pricella Biotechnology Cell STR Testing Service Introduction
11.10.4 Wuhan Pricella Biotechnology Revenue in Cell STR Testing Service Business (2020-2025)
11.10.5 Wuhan Pricella Biotechnology Recent Development
11.11 Shanghai XP Biomed
11.11.1 Shanghai XP Biomed Company Details
11.11.2 Shanghai XP Biomed Business Overview
11.11.3 Shanghai XP Biomed Cell STR Testing Service Introduction
11.11.4 Shanghai XP Biomed Revenue in Cell STR Testing Service Business (2020-2025)
11.11.5 Shanghai XP Biomed Recent Development
11.12 Guangzhou IGE Biotechnology
11.12.1 Guangzhou IGE Biotechnology Company Details
11.12.2 Guangzhou IGE Biotechnology Business Overview
11.12.3 Guangzhou IGE Biotechnology Cell STR Testing Service Introduction
11.12.4 Guangzhou IGE Biotechnology Revenue in Cell STR Testing Service Business (2020-2025)
11.12.5 Guangzhou IGE Biotechnology Recent Development
11.13 Shanghai Zhong Qiao Xin Zhou Biotechnology
11.13.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Details
11.13.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
11.13.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Cell STR Testing Service Introduction
11.13.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Revenue in Cell STR Testing Service Business (2020-2025)
11.13.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Development
11.14 Shanghai Biowing Biotechnology Application
11.14.1 Shanghai Biowing Biotechnology Application Company Details
11.14.2 Shanghai Biowing Biotechnology Application Business Overview
11.14.3 Shanghai Biowing Biotechnology Application Cell STR Testing Service Introduction
11.14.4 Shanghai Biowing Biotechnology Application Revenue in Cell STR Testing Service Business (2020-2025)
11.14.5 Shanghai Biowing Biotechnology Application Recent Development
11.15 Tianjin KMD Bioscience
11.15.1 Tianjin KMD Bioscience Company Details
11.15.2 Tianjin KMD Bioscience Business Overview
11.15.3 Tianjin KMD Bioscience Cell STR Testing Service Introduction
11.15.4 Tianjin KMD Bioscience Revenue in Cell STR Testing Service Business (2020-2025)
11.15.5 Tianjin KMD Bioscience Recent Development
11.16 Wuhan Sunncell
11.16.1 Wuhan Sunncell Company Details
11.16.2 Wuhan Sunncell Business Overview
11.16.3 Wuhan Sunncell Cell STR Testing Service Introduction
11.16.4 Wuhan Sunncell Revenue in Cell STR Testing Service Business (2020-2025)
11.16.5 Wuhan Sunncell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
ATCC
Eurofins Genomics
Promega Corporation
Multiplexio
Shanghai Beyotime
Xiamen Immocell Biotechnology
Wuhan Boster Biological Technology
Beijing Microread Genetics
Beijing Abace Biology
Wuhan Pricella Biotechnology
Shanghai XP Biomed
Guangzhou IGE Biotechnology
Shanghai Zhong Qiao Xin Zhou Biotechnology
Shanghai Biowing Biotechnology Application
Tianjin KMD Bioscience
Wuhan Sunncell
听
听
*If Applicable.
